A股異動 | 普利特漲5% 擬以2.18億元投建1.3Gwh電池產能擴建項目
格隆匯12月5日丨普利特(002324.SZ)盤中漲5.77%,報17.59元,總市值178億元。普利特12月4日晚間公吿,公司控股子公司海四達將使用自籌資金及銀行貸款投資建設年產1.3GWh鈉離子及鋰離子電池數字化工廠項目,項目總投資額2.18億元。此次投資將建成一條兼容鈉離子電池、鋰離子電池的智能自動化生產線。此次擴建產能完成後,將為公司新增年產1.3GWh鈉離子及鋰離子電池生產能力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.